Literature DB >> 35701123

[Effects of nano titanium dioxide on gut microbiota based on human digestive tract microecology simulation system in vitro].

J H Zhang1, J Q Shi1, Z J Chen1, G Jia1.   

Abstract

OBJECTIVE: To explore the effects of oral exposure to titanium dioxide nanoparticles (TiO2 NPs) on the composition and structure of human gut microbiota.
METHODS: The particle size, shape, crystal shape and degree of agglomeration in ultrapure water of TiO2 NPs were characterized. The in vitro human digestive tract microecological simulation system was established by simulating the fluid environment and physical conditions of stomach, small intestine and colon, and the stability of the simulation system was evaluated. The bacterial communities were extracted from human feces and cultured stably in the simulated system. They were exposed to 0, 20, 100 and 500 mg/L TiO2 NPs, respectively, and the bacterial fluids were collected after 24 h of exposure. The effect of TiO2 NPs on the composition and structure of human gut microbiota was analyzed by 16S rRNA sequencing technology. Linear discriminant analysis effect size (LEfSe) was used to screen differential bacteria, and the Kyoto encyclopedia of genes and genomes (KEGG) database for functional prediction.
RESULTS: The spherical and anatase TiO2 NPs were (25.12±5.64) nm in particle size, while in ultra-pure water hydrated particle size was (609.43±60.35) nm and Zeta potential was (-8.33±0.22) mV. The in vitro digestive tract microecology simulation system reached a relatively stable state after 24 hours, and the counts of Enterococci, Enterobacte-rium, and Lactobacillus reached (1.6±0.85)×107, (5.6±0.82)×107 and (2.7±1.32)×107, respectively. 16S rRNA sequencing results showed that compared with the control group, the number and evenness of gut microbiota were not significantly affected at phylum, class, order, family and genus levels in TiO2 NPs groups (20, 100 and 500 mg/L). The relative abundance of some species was significantly changed, and a total of 42 different bacteria were screened between the TiO2 NPs groups (20, 100 and 500 mg/L) and the control group [linear discriminant analysis(LDA) score>3], represented by Enterobacter, Bacteroidaceae, Lactobacillaceae, Bifidobacteriaceae and Clostridium. Further predictive analysis of gut microbiota function showed that TiO2 NPs might affect oxidative phosphorylation, energy meta-bolism, phosphonate and phosphonate metabolism, and methane metabolism (P < 0.05).
CONCLUSION: In human digestive tract microecological simulation system, TiO2 NPs could significantly change the composition and structure of human gut microbiota, represented by Enterobacter and probiotics, and may further affect a variety of metabolism and function of the body.

Entities:  

Keywords:  16S rRNA sequencing technology; Gastrointestinal microbiome; Models, biological; Nanoparticles; Titanium dioxide

Mesh:

Substances:

Year:  2022        PMID: 35701123      PMCID: PMC9197702     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  19 in total

1.  Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging.

Authors:  C Schiller; C-P Fröhlich; T Giessmann; W Siegmund; H Mönnikes; N Hosten; W Weitschies
Journal:  Aliment Pharmacol Ther       Date:  2005-11-15       Impact factor: 8.171

2.  Effect of Long-Term Intake of Dietary Titanium Dioxide Nanoparticles on Intestine Inflammation in Mice.

Authors:  Wei Mu; Yong Wang; Chao Huang; Yijing Fu; Jingquan Li; Hui Wang; Xudong Jia; Qian Ba
Journal:  J Agric Food Chem       Date:  2019-08-07       Impact factor: 5.279

3.  Characterization of food-grade titanium dioxide: the presence of nanosized particles.

Authors:  Yu Yang; Kyle Doudrick; Xiangyu Bi; Kiril Hristovski; Pierre Herckes; Paul Westerhoff; Ralf Kaegi
Journal:  Environ Sci Technol       Date:  2014-05-13       Impact factor: 9.028

Review 4.  Antibacterial properties of nanoparticles.

Authors:  Mohammad J Hajipour; Katharina M Fromm; Ali Akbar Ashkarran; Dorleta Jimenez de Aberasturi; Idoia Ruiz de Larramendi; Teofilo Rojo; Vahid Serpooshan; Wolfgang J Parak; Morteza Mahmoudi
Journal:  Trends Biotechnol       Date:  2012-08-09       Impact factor: 19.536

5.  Characterization, antibacterial, total antioxidant, scavenging, reducing power and ion chelating activities of green synthesized silver, copper and titanium dioxide nanoparticles using Artemisia haussknechtii leaf extract.

Authors:  Mehran Alavi; Naser Karimi
Journal:  Artif Cells Nanomed Biotechnol       Date:  2017-12-12       Impact factor: 5.678

6.  Antimicrobial activity of ZnO-TiO2 nanomaterials synthesized from three different precursors of ZnO: influence of ZnO/TiO2 weight ratio.

Authors:  Ikram Daou; Najia Moukrad; Omar Zegaoui; Fouzia Rhazi Filali
Journal:  Water Sci Technol       Date:  2018-03       Impact factor: 1.915

7.  Effects of oral exposure to titanium dioxide nanoparticles on gut microbiota and gut-associated metabolism in vivo.

Authors:  Zhangjian Chen; Shuo Han; Di Zhou; Shupei Zhou; Guang Jia
Journal:  Nanoscale       Date:  2019-11-28       Impact factor: 7.790

8.  Impact of food grade and nano-TiO2 particles on a human intestinal community.

Authors:  William Dudefoi; Kristy Moniz; Emma Allen-Vercoe; Marie-Hélène Ropers; Virginia K Walker
Journal:  Food Chem Toxicol       Date:  2017-05-28       Impact factor: 6.023

9.  Gastrointestinal microbes increase arsenic bioaccessibility of ingested mine tailings using the simulator of the human intestinal microbial ecosystem.

Authors:  Brian D Laird; Tom R Van de Wiele; Madeleine C Corriveau; Heather E Jamieson; Michael B Parsons; Willy Verstraete; Steven D Siciliano
Journal:  Environ Sci Technol       Date:  2007-08-01       Impact factor: 9.028

Review 10.  Toxicity of Nano-Titanium Dioxide (TiO2-NP) Through Various Routes of Exposure: a Review.

Authors:  Muhammad Shakeel; Farhat Jabeen; Samina Shabbir; Muhammad Saleem Asghar; Muhammad Saleem Khan; Abdul Shakoor Chaudhry
Journal:  Biol Trace Elem Res       Date:  2015-11-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.